Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 19.31
-0.23 (-1.18%)
At close: Feb 13, 2026
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 11.09 billion as of February 13, 2026. Its market cap has decreased by -1.96% in one year.
Market Cap
11.09B
Enterprise Value
8.27B
Revenue
1.67B
Ranking
n/a
PE Ratio
47.92
Stock Price
19.31
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 11.09B, a decrease of -76.12%. That is a compound annual growth rate of -23.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 11.09B | 2.12% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Andon Health | 17.31B |
| Shenyang Xingqi Pharmaceutical | 17.05B |
| Micro-Tech (Nanjing) Co.,Ltd | 14.82B |
| Autek China | 13.76B |
| Jiangsu Hualan New Pharmaceutical Material | 12.80B |
| Tofflon Science and Technology Group | 12.72B |
| Eyebright Medical Technology (Beijing) | 11.51B |
| Tinavi Medical Technologies | 11.43B |